Does aging reduce Leydig cell testosterone production and blunt the testicular response to LH stimulation?

Male aging is characterized by a progressive decline in serum testosterone, driven primarily by intrinsic changes within the testes rather than hypothalamic-pituitary failure alone.

Clinical evidence and secretory reserve

• Human and animal studies demonstrate that physiological aging is directly associated with a lower absolute capacity of Leydig cells to produce testosterone.
• Older males exhibit a blunted testicular endocrine response to acute luteinizing hormone (LH) or human chorionic gonadotropin (hCG) stimulation, resulting in a significantly smaller absolute increment in testosterone compared to younger controls. This blunted response reflects a depleted secretory reserve.

Mechanistic pathways and oxidative stress

• Oxidative stress: Aging leads to a chronic increase in reactive oxygen species (ROS) and diminished antioxidant defenses within Leydig cells.
• Cholesterol transport: Elevated oxidative stress downregulates Star gene transcription and impairs the expression of the steroidogenic acute regulatory (StAR) protein and the translocator protein (TSPO). Because StAR is the rate-limiting gatekeeper mediating mitochondrial cholesterol transport, its loss severely restricts substrate delivery.
• Enzymatic decline: This defect is compounded by impaired LH-stimulated cAMP signaling and a corresponding age-dependent decrease in the catalytic activity of essential downstream steroidogenic enzymes, including CYP11A1, CYP17A1, HSD3B, and HSD17B3.

Bottom line

• Aging is robustly associated with reduced testosterone production and a blunted testicular response to LH stimulation. This hyporesponsiveness is driven by intrinsic Leydig cell dysfunction characterized by chronic oxidative stress, impaired StAR-mediated mitochondrial cholesterol transport, and diminished steroidogenic enzyme activity.